Clinical and Radiographic Evaluation of Two Newly Pulp Medicaments Used in Primary Molars PulpotomyEl-Morsy Badran MM1*, Awad SM2 and Shalan HM1
- *Corresponding Author:
- Badran El-Morsy MM
Faculty of Dentistry
Pediatric Dentistry and Dental Public Health Department
Mansoura University, Egypt
E-mail: [email protected]
Received Date: February 10, 2017; Accepted Date: March 15, 2017; Published Date: March 25, 2017
Citation: El-Morsy Badran MM, Awad SM, Shalan HM (2017) Clinical and Radiographic Evaluation of Two Newly Pulp Medicaments Used in Primary Molars Pulpotomy. Pediatr Dent Care 2:135.
Copyright: © 2017 El-Morsy Badran MM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Primary molars pulpotomy is a very common therapy for primary molars with extensive caries. Many agents including formaldehydebased materials, electro surgery, lasers, glutaraldehyde, haemostatic medicaments, zinc oxide eugenol, bone morphogenic protein (BMP), collagen and calcium involving, Dentin Bridge inducing materials have been developed. However, the ideal pulpotomy treatment still needs to be improved, so this research was done.